A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis

被引：99

作者：

Hu, Miaofen G. ^{[1
]}

Deshpande, Amit ^{[4
]}

Enos, Miriam ^{[1
]}

Mao, Daqin ^{[1
]}

Hinds, Elisabeth A. ^{[1
]}

Hu, Guo-fu ^{[2
]}

Chang, Rui ^{[1
,3
]}

Guo, Zhuyan ^{[1
,5
]}

Dose, Marei ^{[1
,6
]}

Mao, Changchuin ^{[1
]}

Tsichlis, Philip N. ^{[1
]}

Gounari, Fotini ^{[1
,6
]}

Hinds, Philip W. ^{[1
]}

机构：

[1] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA

[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

[4] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA

[5] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA

[6] Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA

来源：

CANCER RESEARCH | 2009年 / 69卷 / 03期

关键词：

T-CELL DEVELOPMENT; SIGNALING PATHWAY; GENE-EXPRESSION; NOTCH; INDUCTION; INSULIN; LINEAGE; CDK6; FATE; SUPPRESSION;

D O I：

10.1158/0008-5472.CAN-08-2473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cyclin-dependent kinase 6 (CDK6) promotes cell cycle progression and is overexpressed in human lymphoid malignancies. To determine the role of CDK6 in development and tumorigenesis, we generated and analyzed knockout mice. Cdk6-deficient mice show pronounced thymic atrophy due to reduced proliferative fractions and concomitant transitional blocks in the double-negative stages. Using the OP9-DL1 system to deliver temporally controlled Notch receptor-dependent signaling, we show that CDK6 is required for Notch-dependent survival, proliferation, and differentiation. Furthermore, CDK6-deficient mice were resistant to lympho-magenesis induced by active Akt, a downstream target of Notch signaling. These results show a critical requirement for CDK6 in Notch/Akt-dependent T-cell development and tumorigenesis and strongly support CDK6 as a specific therapeutic target in human lymphoid malignancies. [Cancer Res 2009; 69(3):810-8]

引用

页码：810 / 818

页数：9

共 38 条

[1] Mechanism of activation of protein kinase B by insulin and IGF-1
Alessi, DR
Andjelkovic, M
Caudwell, B
Cron, P
Morrice, N
Cohen, P
Hemmings, BA
[J]. EMBO JOURNAL, 1996, 15 (23) : 6541 - 6551
[2] Notch signaling: Cell fate control and signal integration in development
Artavanis-Tsakonas, S
Rand, MD
Lake, RJ
[J]. SCIENCE, 1999, 284 (5415) : 770 - 776
[3] Notch signaling in leukemia
Aster, Jon C.
Pear, Warren S.
Blacklow, Stephen C.
[J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2008, 3 : 587 - 613
[4] Core transcriptional regulatory circuitry in human embryonic stem cells
Boyer, LA
Lee, TI
Cole, MF
Johnstone, SE
Levine, SS
Zucker, JR
Guenther, MG
Kumar, RM
Murray, HL
Jenner, RG
Gifford, DK
Melton, DA
Jaenisch, R
Young, RA
[J]. CELL, 2005, 122 (06) : 947 - 956
[5] Chilosi M, 1998, AM J PATHOL, V152, P209
[6] Notch promotes survival of pre-T cells at the β-selection checkpoint by regulating cellular metabolism
Ciofani, M
Zúñiga-Pflücker, JC
[J]. NATURE IMMUNOLOGY, 2005, 6 (09) : 881 - 888
[7] Expression of G1-phase cell cycle genes during hematopoietic lineage
DellaRagione, F
Borriello, A
Mastropietro, S
DellaPietra, V
Monno, F
Gabutti, V
Locatelli, F
Bonsi, L
Bagnara, GP
Iolascon, A
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (01) : 73 - 76
[8] Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, JA
Cheng, MG
Roussel, MF
Sherr, CJ
[J]. GENES & DEVELOPMENT, 1998, 12 (22) : 3499 - 3511
[9] Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice
Engel, I
Murre, C
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11322 - 11327
[10] CONTROL POINTS IN EARLY T-CELL DEVELOPMENT
GODFREY, DI
ZLOTNIK, A
[J]. IMMUNOLOGY TODAY, 1993, 14 (11): : 547 - 553

← 1 2 3 4 →